FOXO4 – 10 mg
FOXO4 – 10 mg FOXO4-DRI (Proxofim) is a synthetic peptide that has been explored in research for its potential role in cellular longevity. It is designed to target senescent cells, sometimes referred to as "zombie" cells, which are cells that have stopped dividing but remain metabolically active and can contribute to aging processes and age-related conditions. FOXO4-DRI is thought to induce apoptosis (programmed cell death) in these senescent cells by interfering with the interaction between FOXO4 and p53 proteins.
Research Use Only Disclaimer
FOR RESEARCH USE ONLY This product is not intended for human or animal use.Not for medical, diagnostic, therapeutic, longevity-related, regenerative, or consumption purposes.No dosage, administration, or biological outcome claims are made or implied.Use is restricted to qualified laboratory research environments only.
❓Frequently Asked Questions
Is FOXO4 approved for medical or anti-aging use?
No. This product is supplied strictly for laboratory research purposes.
Does this product include a Certificate of Analysis (COA)?
Yes. Every batch includes a third-party verified COA.
Why is FOXO4 supplied in a 10 mg research format?
This quantity supports extended analytical testing, structural studies, and reference evaluation, not consumption.
Can this compound be used in humans or animals?
No. It is not approved for use in living systems.
How is this product classified?
It is classified solely as a research peptide, not a drug, supplement, or therapeutic agent.